AML
Item
patient with aml and >=18 years of age.
boolean
C0023467 (UMLS CUI [1])
Informed Consent
Item
Patient agrees to participate in the study and signs the informed consent
boolean
C0021430 (UMLS CUI [1])
Peripheral blood mononuclear cell
Item
viably frozen cells from the time of diagnosis or relapse are available
boolean
C1321301 (UMLS CUI [1])
In complete remission
Item
first complete remission and have high risk features of relapse.
boolean
C0677874 (UMLS CUI [1])
Blast Cell
Item
less than 10% blast cells in the bone marrow following induction or re-induction therapy and not desiring further intensive treatment.
boolean
C0368761 (UMLS CUI [1])
Creatinine
Item
acceptable creatinine, ast, alp, bilirubin
boolean
C0010294 (UMLS CUI [1])
Contraceptive methods
Item
agree to use contraception
boolean
C0700589 (UMLS CUI [1])
Not pregnant
Item
not pregnant
boolean
C0232973 (UMLS CUI [1])
comply with study procedures
Item
able to comply with study procedures
boolean
C0525058 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status <2
boolean
C1520224 (UMLS CUI [1])
Persistent infection
Item
known persistent infection
boolean
C1264606 (UMLS CUI [1])
cns disease
Item
known cns disease
boolean
C0007682 (UMLS CUI [1])
Blast Cell
Item
greater than 10% blasts in the bone marrow or circulating blast cells
boolean
C0368761 (UMLS CUI [1])
Life Expectancy
Item
life expectancy < 2 months
boolean
C0023671 (UMLS CUI [1])
Leukemic Cells
Item
receiving any chemotherapy, corticosteroids, cox2 inhibitors or any non-drug therapies with the intent of altering the immune response or kill leukemic cells within one week prior to infusion of il-12 -infected cells.
boolean
C0301872 (UMLS CUI [1])
C3890400 (UMLS CUI [2])